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Effect of 1 year krill oil supplementation on depression and self-
esteem in typically developing Dutch adolescents:  
Preliminary results 
Research Question 
What is the influence of 1 year of krill oil supplementation in 13-15 
year old adolescents attending lower general secondary education 
on:  
 
 
 
 
Cognitive functioning and academic 
achievement?   
Mood and self-esteem?   
Sleep quality and quantity and visual 
processing?   
baseline 
Dose adjustment 
12 months 6 months 3 months 
Krill: 
520mg EPA p/day 
280mg DHA p/day 
Omega-3 
Index<5% 
 
Inclusion  
Placebo: 
0 mg EPA p/day 
0 mg DHA p/day 
or 
Study design 
Unique  
characteristics 
Adolescents 
 
Lower general secondary education 
(TL/MAVO) 
 
 
Selection <5% Omega-3 Index  
 
 
Personalised dose-adjustment after 3 
months 
 
 
Supplement consumed at dinner time   
 
Mood and Self-esteem 
Test Measures  
Center of Epidemiology 
Studies Depression Scale – 
Dutch version 
Depression  
Rosenberg Self-esteem 
questionnaire 
Self-esteem  
Assessed for eligibility (n=286) 
Excluded  (n=19) 
● Not meeting inclusion criteria (n=17) 
●  Declined to participate (n=1) 
● Other reasons (n=2) 
Flow chart 
Randomized  (n = 267) 
Placebo (n =133) Krill (n = 134) 
Lost to follow-up (n=25) 
Forgetting  (n=8) 
Difficulty swallowing 
(n=6) 
Motivation (n=4) 
Reason not given (n=4) 
Dose adjustment (n=3) 
 
Lost to follow-up (n=31) 
Forgetting  (n=2) 
Difficulty swallowing (n=8) 
Motivation (n=15) 
Reason not given (n=3) 
Dose adjustment (n=1) 
Personal (n=1)  
Other (n=1) 
 
Discontinued intervention 
(n=49) 
Forgetting  (n=13) 
Difficulty swallowing (n=5) 
Motivation (n=15) 
Reason not given (n=3)  
Dose adjustment (n=3) 
Personal (n=3) 
Other (n=7)  
 
Discontinued intervention 
(n=38) 
Forgetting  (n=7) 
Difficulty swallowing (n=9) 
Motivation (n=11) 
Reason not given (n=2) 
Dose adjustment (n=4) 
Personal (n=1) 
Other (n=2)  
Analysed intention to treat (n=106) 
Excluded from analysis (n=3) 
◦ Included in RCT but Omega-3 Index >5% (n =3) 
Analysed intention to treat  (n=97) 
Excluded from analysis (n=7) 
◦ Included in RCT but Omega-3 Index >5% (n =6)  
◦ Quit during test moment 1 (n =1) 
 
withdrew consent (n =1)  
Statistics baseline  
• Bayesian analyses  
 
• Baseline data  corrected for:  
– CESD: smoking, sex and BMI  
– RSE: smoking, diagnosis and sex  
 
• CESD used as a continuous variable, for 
descriptive purposes CESD > 16 as depressed.   
• Frequents analyses non-significant result: 
– There is evidence for the H0 (i.e. there is no 
association) or  
– The data are insensitive in distinguishing the H1 from 
the H0 (i.e. nothing follows from the data)  
• Bayesian analyses, Bayes Factor  
– There is evidence for H0 (BF >3) 
– There is evidence for H1 (BF< 0.33) 
– Data is not sensitive (i.e. nothing follows from the 
data; BF = 0.33-1)  
 
Frequenst vs Bayesian   
Baseline characteristics  
1 Smoking ‘yes’ was defined as anybody who indicated to smoke more than 0 cigarettes per week.  
2 Diagnosis was indicated by students themselves and included (but not limited to) dyslexia, 
dyscalculia, depression, autism and ADHD.  
3 Alcohol consumption was asked as how many times per week and units per consumption 
moment, alcohol per week is defined as these factors multiplied.  
  N Mean SD Fatty acid 
(%wt/wt of total FA, 
except for O3I) 
N Mean SD 
Age (years) 257 14.11 0.50 Omega-3 Index 257 3.78 0.56 
Male/Female 257 124/133 
[48.2/51.8%] 
- 
DHA 22:6n-3 
257 2.55 0.46 
Smoking 
no/yes1 
255 231/24 
[89.9/9.3%] 
- 
EPA 20:5n-3 
257 0.38 0.15 
BMI 240 19.98 3.00 DPA 22:5n-3 257 1.22 0.19 
Alcohol units 
per week2 
256 0.47 1.80 
AA 20:4n-6 
257 11.15 1.27 
LPE 240 5.05 1.5 ObA 22:5n-6 257 0.44 0.10 
Depression  
• 29.4% scored CESD ≥16 
– Girls: 42.3% ≥16 
– Boys: 15.6%  ≥16 
• 17.1% scored CESD ≥22 
 
• Those with depression: more girls, higher BMI, 
further in puberty, lower self-esteem.  
Baseline results  
  One fatty acid     
All fatty 
acids in 1 
model 
    
Predictor 
fatty acid  
Regression 
coefficient 
95% 
credibility 
interval1 
BF10 2   
Regression 
coefficient 
95% 
credibility 
interval 
BFomit3 
Omega-3 
Index -0.016 -0.14;0.11 0.14         
DHA -0.04 -0.16;0.08 0.15 DHA -0.02 -0.15;0.11 3.12 
EPA 0.06 -0.06;0.18 0.34 EPA 0.09 -0.05;0.22 1.42 
AA -0.13 -0.25;-0.02 2.65 AA -0.03 -0.18;0.11 2.79 
DPA -0.13 -0.24;-0.02 1.01 DPA -0.11 -0.25;0.03 0.84 
ObA  -0.16 -0.28;-0.04 251.95 ObA -0.09 -0.22;0.03 1.20 
O3I = Omega-3 Index 
One fatty acid model, is a model in which only one predictor of interest is entered (Omega-3 Index, DHA, EPA, AA, DPA, or ObA). All 
fatty acids model is a model in which all fatty acids (DHA, EPA, AA, DPA, and ObA) are entered, i.e. for example the association 
between DHA and self-esteem is corrected for the other fatty acids (EPA, AA, DPA, ObA).  
All analyses were adjusted for BMI, smoking (yes/no), and sex.  
1 Credibility intervals are analogous to confidence intervals in traditional statistics.  
2 BF10 refers to the evidence for the model with the specific fatty acid compared to a model with only covariates. 
3 BFomit indicates whether the model improves with the omission of that specific fatty acid. BFomit numbers above 3 indicate that 
keeping the variable in the model is not preferable. 
Self-esteem 
  One fatty acid     
All fatty 
acids in one 
model 
    
Predictor 
fatty acid  
Regression 
coefficient 
95% 
credibility 
interval1 
BF10 2   
Regression 
coefficient 
95% 
credibility 
interval 
BFomit 3 
Omega-3 
Index -0.05 -0.18;0.08 0.18         
DHA -0.03 -0.15;0.10 0.15 DHA 0.001 -0.13;0.13 3.12 
EPA -0.09 -0.20;0.03 0.32 EPA -0.08 -0.21;0.05 1.59 
AA 0.008 -0.12;0.10 0.14 AA -0.06 -0.20;0.08 2.04 
DPA -0.02 -0.09;0.14 0.16 DPA 0.07 -0.07;0.20 1.76 
ObA  0.09 -0.03;0.20 4.15 ObA 0.07 -0.05;0.20 1.63 
O3I = Omega-3 Index 
One fatty acid model, is a model in which only one predictor of interest is entered (Omega-3 Index, DHA, EPA, AA, DPA, or ObA). All 
fatty acids model is a model in which all fatty acids (DHA, EPA, AA, DPA, and ObA) are entered, i.e. for example the association 
between DHA and self-esteem is corrected for the other fatty acids (EPA, AA, DPA, ObA).  
All analyses were adjusted for BMI, smoking (yes/no), and sex.  
1 Credibility intervals are analogous to confidence intervals in traditional statistics.  
2 BF10 refers to the evidence for the model with the specific fatty acid compared to a model with only covariates. 
3 BFomit indicates whether the model improves with the omission of that specific fatty acid. BFomit numbers above 3 indicate that 
keeping the variable in the model is not preferable. 
Intervention  
Change in fatty acids (ITT)  
fatty acid  
(%wt/wt of 
total FA) 
condition baseline 3 months 6 months 12 months 
AA 20:4n-6 Placebo 11.19 ± 1.36 10.97 ± 1.18 11.02 ± 1.49 11.15 ± 1.30 
Krill 11.12 ± 1.18 10.26 ± 1.13* 10.28 ± 1.41 * 10.702± 1.49* 
EPA 20:5n-3 Placebo 0.38 ± 0.14 0.43 ± 0.15 0.41 ± 0.14 0.40 ± 0.12 
Krill 0.38 ± 0.15 0.93 ± 0.58* 0.95 ± 0.69* 0.75 ± 0.58* 
ObA 22:5n-6 Placebo 0.43 ± 0.11 0.41 ± 0.17 0.42 ± 0.09 0.38 ± 0.12 
Krill 0.45 ± 0.10 0.32 ± 0.12* 0.32 ± 0.11* 0.34 ± 0.13* 
DPA 22:5n-3  Placebo 1.22 ± 0.20 1.29 ± 0.23 1.30 ± 0.20 1.30 ± 0.19 
Krill 1.22 ± 0.17 1.58 ± 0.34* 1.54 ± 0.35* 1.47 ± 0.31 * 
DHA 22:6n-3 Placebo 2.60 ± 0.44 2.61 ± 0.52 2.69 ± 0.53 2.72 ± 0.54 
Krill 2.49 ± 0.46 3.25 ± 0.73* 3.40 ± 0.90* 3.20 ± 0.84* 
* Krill oil and placebo condition are significantly different p<0.05 
Change in Omega-3 Index over time  
* * * 
* Krill oil and placebo condition are significantly different p<0.05 
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In comparison 
Target group Omega-3 index  
Unselected Japanese men (n 262) 9.58 
Unselected Germans (n 5000) 7.15 ± 2.19 
Unselected Europeans (n 10000) 6.96 ± 2.15 
Framingham-Offspring (n 3196) 4.90 ± 2.10 
American adolescents with major depression (n 150)  3.46 
Americans with major depression (n 118) 2.90 ± 1.50 
Adapted from:  Von Schacky , C. Omega-3 index and cardiovascular health. Nutrients 2014;6:799–814. 
doi:10.3390/nu6020799  
Depression 
Depression 
>15 
Baseline 6 months 12 months  
No 70.6% 78.7% 73.5% 
Yes 29.4% 21.3% 26.5%  
Depression 
>21  
No 82.9% 88% 81.4% 
Yes 17.1% 12% 18.6% 
Analyses  
• Multilevel analyses – with person as unit  
• Intention to treat and according to blood Omega-3 Index 
• Correction for covariates 
– Drinking (units per week)  
– Smoking (yes/no)  
– Age at baseline 
– BMI (self-reported at baseline)  
– Sex 
– Cohort number  
– Diagnosis which can influence learning (yes/no)  
– Test moment  
– Level of parental education (low/high) 
– In condition analyses: condition*test moment  
 
 
Results depression  
 
ITT analyses: 
B = - -0.64 
p = 0.624 
95% CI: -3.19 to 1.90 
 
Results depression  
 
Omega-3 Index: 
B = 0.38 
p = 0.264 
95% CI: -0.28 to 1.30 
 
Test moment  
Other fatty acids  
 
CES-D Beta P 95% CI 
DHA -0.17 0.749 [-1.17; 0.84] 
EPA 0.68 0.399 [-0.88; 2.23] 
DPA -0.71 0.604 [-3.36; 1.94] 
AA -0.36 0.165 [-0.86; 0.14] 
OBA -4.07 0.198 [-10.19; 2.06] 
Results: self-esteem 
 
ITT analyses: 
B = 0.28 
p = 0.721 
95% CI: -1,22; 1,77 
 
 
Omega-3 Index: 
B = -0.03 
p = 0.866 
95% CI: -0.38 to 0.32 
 
Test moment  
Results: self-esteem 
Other fatty acids  
RSE Beta P 95% CI 
DHA 0.08 0.761 [-0.45; 0.61] 
EPA -0.14 0.736 [-0.96; 0.68] 
DPA -0.41 0.573 [-1.83; 1.00] 
AA -0.13 0.367 [-0.39; 0.14] 
OBA -1.61 0.333 [-4.85; 1.62] 
Discussion (1)  
• Depression is very common in adolescents.  
• No significant effects of supplementation on 
depression and self-esteem.  
• Even analyses according to omega-3 fatty acid 
status did not show effects  
• 1 year of krill oil, still low Omega-3 Index 
– Did not take capsules – compliance  
– Factors associated with metabolism  
– Krill oil  
 
Discussion (2)   
• Important to take blood values! 
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